SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) OCTOBER 1, 2002
----------------
NOVADEL PHARMA INC.
-----------------------------------------------------
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE 000-23399 22-2407152
--------------------------------------------------------------------------
(STATE OR OTHER (COMMISSION (IRS EMPLOYER
JURISDICTION OF FILE NUMBER) IDENTIFICATION NO.)
FORMATION)
31 STATE HIGHWAY 12 FLEMINGTON, NJ 08822
-----------------------------------------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE (908) 782-3431
--------------
FLEMINGTON PHARMACEUTICAL CORPORATION
-----------------------------------------------------------
(FORMER NAME OR FORMER ADDRESS, IF CHANGES SINCE LAST REPORT)
ITEM 5. OTHER EVENTS.
------------
On October 1, 2002, Flemington Pharmaceutical Corporation, a Delaware
corporation, changed its name to "Novadel Pharma Inc." (the "Company") by
amending its Certificate of Incorporation. On October 3, 2002, the Company's
trading symbol on the OTC Bulletin Board was changed to "NVDL" to reflect the
change in the Company's name.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA INFORMATION AND EXHIBITS.
--------------------------------------------------------
(c) Exhibits
99 Press Release dated October 2, 2002.
ITEM 9. REGULATION FD DISCLOSURE.
------------------------
Exhibit 99 hereto sets forth a press release issued by the Company to
report the name change and additional information about the Company.
1
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly authorized and caused the undersigned to sign this Report on
the Registrant's behalf.
NOVADEL PHARMA INC.
By:/s/Harry A. Dugger, III
-----------------------
Name: Harry A. Dugger, III
Title: President and Chief Executive
Officer
Dated: October 3, 2002
2